Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Synaptogenix Inc

SNPX
Current price
2.33 USD +0.026 USD (+1.11%)
Last closed 2.27 USD
ISIN US87167T2015
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 195 752 USD
Yield for 12 month -47.78 %
1Y
3Y
5Y
10Y
15Y
SNPX
21.11.2021 - 28.11.2021

Synaptogenix, Inc. operates as a biopharmaceutical company. The company is primarily focused on developing a product platform based upon Bryostatin-1, for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. It is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing. The company was incorporated in 2012 and is headquartered in New York, New York. Address: 1185 Avenue of the Americas, New York, NY, United States, 10036

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

14.00 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

-6 347 USD

Current Quarter

Last Quarter

Key Figures SNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 805 152 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -17.43 %
PEG Ratio
Return On Equity TTM -78.91 %
Wall Street Target Price 14.00 USD
Revenue TTM
Book Value 4.32 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -10.99 USD
Diluted Eps TTM -10.99 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics SNPX

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History SNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:25
Payout Ratio TTM
Last Split Date 05.04.2024

Stock Valuation SNPX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.28
Price Book MRQ 0.53

Financials SNPX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SNPX

For 52 weeks

1.84 USD 5.38 USD
50 Day MA 2.57 USD
Shares Short Prior Month 19 283
200 Day MA 3.13 USD
Short Ratio 1.65
Shares Short 11 978
Short Percent 0.89 %